PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of canfamphysLink to Publisher's site
 
Can Fam Physician. 1999 January; 45: 126–132.
PMCID: PMC2328025

Hereditary breast cancer. Psychosocial issues and family physicians' role.

Abstract

OBJECTIVES: To outline the psychosocial issues in hereditary breast cancer (HBC) assessment and discuss the role of family physicians. QUALITY OF EVIDENCE: A literature search using MEDLINE, CINAHL, CancerLit, and HealthStar databases was conducted from January 1990 to April 1998, using the key words breast cancer or neoplasm and familial or hereditary, genetic testing or screening, primary care or family physician or counseling, genetic counseling, psychosocial or psychological. We found only a few studies focusing on a small number of well-studied "research families." MAIN FINDINGS: Women with a family history of breast cancer were likely to be highly interested in genetic testing for cancer risk. The benefit of testing for those with negative results is reassurance. Those found to be carriers of genetic mutations might benefit from increased surveillance and prophylactic therapy. Risks of testing include anxiety, depression, guilt, altered self-image, and insurance and employment discrimination. A family physician's role is to assess risk, to provide information and support so women can make informed choices about referral to familial cancer clinics, to offer cancer surveillance, and to provide support once genetic test results are available. CONCLUSION: Genetic testing is rapidly moving from research to clinical applications. Family physicians play an integral role in educating and managing women at risk for HBC. Physicians must prepare themselves with knowledge and counseling skills to meet the challenges of this new technology.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.6M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Sharpe NF. Genetic screening and testing in Canada: a model duty of care. Health Law J. 1996;4:119–134. [PubMed]
  • Dickens BM, Pei N, Taylor KM. Legal and ethical issues in genetic testing and counseling for susceptibility to breast, ovarian and colon cancer. CMAJ. 1996 Mar 15;154(6):813–818. [PMC free article] [PubMed]
  • Andrykowski MA, Lightner R, Studts JL, Munn RK. Hereditary cancer risk notification and testing: how interested is the general population? J Clin Oncol. 1997 May;15(5):2139–2148. [PubMed]
  • Chaliki H, Loader S, Levenkron JC, Logan-Young W, Hall WJ, Rowley PT. Women's receptivity to testing for a genetic susceptibility to breast cancer. Am J Public Health. 1995 Aug;85(8 Pt 1):1133–1135. [PubMed]
  • Lerman C, Daly M, Masny A, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol. 1994 Apr;12(4):843–850. [PubMed]
  • Struewing JP, Lerman C, Kase RG, Giambarresi TR, Tucker MA. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev. 1995 Mar;4(2):169–173. [PubMed]
  • Botkin JR, Croyle RT, Smith KR, Baty BJ, Lerman C, Goldgar DE, Ward JM, Flick BJ, Nash JE. A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing. J Natl Cancer Inst. 1996 Jul 3;88(13):872–882. [PubMed]
  • Jacobsen PB, Valdimarsdottier HB, Brown KL, Offit K. Decision-making about genetic testing among women at familial risk for breast cancer. Psychosom Med. 1997 Sep-Oct;59(5):459–466. [PubMed]
  • Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G, Gold K, Trock B, Main D, Lynch J, et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA. 1996 Jun 26;275(24):1885–1892. [PubMed]
  • Lynch HT, Lemon SJ, Durham C, Tinley ST, Connolly C, Lynch JF, Surdam J, Orinion E, Slominski-Caster S, Watson P, et al. A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer. 1997 Jun 1;79(11):2219–2228. [PubMed]
  • Marteau TM, van Duijn M, Ellis I. Effects of genetic screening on perceptions of health: a pilot study. J Med Genet. 1992 Jan;29(1):24–26. [PMC free article] [PubMed]
  • Biesecker BB, Boehnke M, Calzone K, Markel DS, Garber JE, Collins FS, Weber BL. Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA. 1993 Apr 21;269(15):1970–1974. [PubMed]
  • Kash KM, Holland JC, Halper MS, Miller DG. Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst. 1992 Jan 1;84(1):24–30. [PubMed]
  • Croyle Robert T, Achilles Jennifer S, Lerman Caryn. Psychologic aspects of cancer genetic testing: a research update for clinicians. Cancer. 1997 Aug 1;80(3 Suppl):569–575. [PubMed]
  • Macdonald KG, Doan B, Kelner M, Taylor KM. A sociobehavioural perspective on genetic testing and counselling for heritable breast, ovarian and colon cancer. CMAJ. 1996 Feb 15;154(4):457–464. [PMC free article] [PubMed]
  • Lerman C, Croyle RT. Emotional and behavioral responses to genetic testing for susceptibility to cancer. Oncology (Williston Park) 1996 Feb;10(2):191–202. [PubMed]
  • Bryant HE, Brasher PM. Risks and probabilities of breast cancer: short-term versus lifetime probabilities. CMAJ. 1994 Jan 15;150(2):211–216. [PMC free article] [PubMed]
  • Nguyen HN, Averette HE, Janicek M. Ovarian carcinoma. A review of the significance of familial risk factors and the role of prophylactic oophorectomy in cancer prevention. Cancer. 1994 Jul 15;74(2):545–555. [PubMed]
  • Reiser G, Schaefer GB. Gene testing for cancer susceptibility. Nebr Med J. 1996 Dec;81(12):416–418. [PubMed]
  • DudokdeWit AC, Tibben A, Frets PG, Meijers-Heijboer EJ, Devilee P, Klijn JG, Oosterwijk JC, Niermeijer MF. BRCA1 in the family: a case description of the psychological implications. Am J Med Genet. 1997 Jul 11;71(1):63–71. [PubMed]
  • Codori AM. Psychological opportunities and hazards in predictive genetic testing for cancer risk. Gastroenterol Clin North Am. 1997 Mar;26(1):19–39. [PubMed]
  • Lerman C, Hughes C, Lemon SJ, Main D, Snyder C, Durham C, Narod S, Lynch HT. What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. J Clin Oncol. 1998 May;16(5):1650–1654. [PubMed]
  • Burke W, Daly M, Garber J, Botkin J, Kahn MJ, Lynch P, McTiernan A, Offit K, Perlman J, Petersen G, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA. 1997 Mar 26;277(12):997–1003. [PubMed]
  • Lerman C, Rimer BK, Engstrom PF. Cancer risk notification: psychosocial and ethical implications. J Clin Oncol. 1991 Jul;9(7):1275–1282. [PubMed]
  • Kash KM, Holland JC, Osborne MP, Miller DG. Psychological counseling strategies for women at risk of breast cancer. J Natl Cancer Inst Monogr. 1995;(17):73–79. [PubMed]
  • Thirlaway K, Fallowfield L. The psychological consequences of being at risk of developing breast cancer. Eur J Cancer Prev. 1993 Nov;2(6):467–471. [PubMed]
  • Mark HF, Annas G, Ricker R, Weitzel J. Clinical and research issues in breast cancer genetics. Ann Clin Lab Sci. 1996 Sep-Oct;26(5):396–408. [PubMed]
  • Vasen HF. Screening in breast cancer families: is it useful? Ann Med. 1994 Jun;26(3):185–190. [PubMed]
  • Lerman C, Lustbader E, Rimer B, Daly M, Miller S, Sands C, Balshem A. Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst. 1995 Feb 15;87(4):286–292. [PubMed]
  • Lerman C, Biesecker B, Benkendorf JL, Kerner J, Gomez-Caminero A, Hughes C, Reed MM. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst. 1997 Jan 15;89(2):148–157. [PubMed]
  • Hoskins KF, Stopfer JE, Calzone KA, Merajver SD, Rebbeck TR, Garber JE, Weber BL. Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. JAMA. 1995 Feb 15;273(7):577–585. [PubMed]
  • Biesecker BB, Garber JE. Testing and counseling adults for heritable cancer risk. J Natl Cancer Inst Monogr. 1995;(17):115–118. [PubMed]
  • Green MJ, Fost N. An interactive computer program for educating and counseling patients about genetic susceptibility to breast cancer. J Cancer Educ. 1997 Winter;12(4):204–208. [PubMed]
  • Evans DG, Burnell LD, Hopwood P, Howell A. Perception of risk in women with a family history of breast cancer. Br J Cancer. 1993 Mar;67(3):612–614. [PubMed]
  • Geller Gail, Holtzman Neil A. Implications of the human genome initiative for the primary care physician. Bioethics. 1991 Oct;5(4):318–325. [PubMed]
  • Couch FJ, DeShano ML, Blackwood MA, Calzone K, Stopfer J, Campeau L, Ganguly A, Rebbeck T, Weber BL. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med. 1997 May 15;336(20):1409–1415. [PubMed]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada